Peter Bjerring

Peter Bjerring

Auto-generated profile, based on publicly available information

Peter Bjerring

Department of Dermatology Aalborg University Hospital Aalborg Denmark

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1991 in The Clinical Journal of Pain
Verified
Journal Article
Closed access
RZRobert Zachariae
Robert Zachariae
PBP. Bjerring
P. Bjerring
LALars Arendt-Nielsen
Lars Arendt-Nielsen
TNT. M.A. Nielsen
T. M.A. Nielsen
KGK. M.A. Gotliebsen
K. M.A. Gotliebsen
The relationship between pain perception and emotional states is well known. However, the nature of this relationship and how different emotional states affect sensory and cognitive dimensions of pain remains uncertain. Results from experimental investigations are often contradictory, which may be due to methodological difficulties in inducing pain and monitoring physiological responses. In addition, most studies have focused on a single emotion, and data on the relative effects of different emotional states are lacking. In the present study we attempted to eliminate some of these methodological problems. Laser evoked potentials were used as a quantitative correlate to pain perception and were measured in 12 highly hypnotically susceptible subjects during seven conditions: (a) a prehypnotic baseline condition; (b) a neutral hypnotic control condition; (c—e) hypnotically recalled anger, fear, and depression in randomized order; (f) a hypnotically recalled happy condition, and (g) a posthypnotic awake control condition. The pain evoked potentials were significantly decreased in the angry condition and significantly increased in the depressed condition compared with baseline. No differences could be detected for either the happy or the fear-related condition compared with the baseline or neutral hypnotic condition. A significant positive correlation between the subjective intensity of depression and the increase in evoked potentials was found, but none for the other three emotions. The results support earlier findings that clinical depression is related to increased pain perception, and findings that the expression of anger can inhibit the experience of pain. The lack of changes in pain-related potentials during the neutral and happy condition may indicate that effects of psychological interventions such as hypnotic analgesia may be due to specific cognitive processes rather than a relaxed or pleasant state in itself.

29 May 2025 in Photochemical & Photobiological Sciences
Verified
Journal Article
Open access
PDF file
CPCelina Pihl
Celina Pihl
RKRozarin Delal Kara
Rozarin Delal Kara
JGJonatan Riber Granborg
Jonatan Riber Granborg
UOUffe Høgh Olesen
Uffe Høgh Olesen
PBPeter Bjerring
Peter Bjerring
CLCatharina Lerche
Catharina Lerche
Keratinocyte carcinoma is the most common cancer. Oral photoprotection offers an attractive addition to classical prevention measures. Popular candidates include nicotinamide and nicotinamide mononucleotide (NMN), which are NAD+ precursors thought to facilitate DNA repair. Extracts from the Polypodium leucotomos plant (PL) are also reported to convey broad protection against ultraviolet radiation (UVR) in both human and animal models. In this study, we evaluated the efficacy of NMN and PL treatment to prevent UVR-induced tumor development in hairless mice. Oral treatment with NMN or PL did not affect tumor development evaluated by tumor onset, number, size, or growth. Oral NMN increased NAD+ content in skin compared to the UVR control (p ≤ 0.00039) and liver tissue compared to the UVR control and non-exposed mice (p ≤ 0.0466) with no effect on tumor growth. We also demonstrated that UVR exposure induced urinary excretion of thymidine dimers in mice as measured by liquid chromatography–mass spectrometry, indicating that the induction of photodamage can be monitored non-invasively throughout the study period.

1 July 1991 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
LALars Arendt-Nielsen
Lars Arendt-Nielsen
EAE. Anker-Møller
E. Anker-Møller
PBP. Bjerring
P. Bjerring
NSN. Spangsberg
N. Spangsberg

5 May 2026 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
PBPeter Bjerring
Peter Bjerring
ZDZoe Diana Draelos
Zoe Diana Draelos
SFSabrina G. Fabi
Sabrina G. Fabi
GGGreg Julian Goodman
Greg Julian Goodman
KHKwun Cheung Hau
Kwun Cheung Hau
LXLeihong Xiang
Leihong Xiang
Background: Integrated skincare (ISC) combines dermocosmetics with medical aesthetic procedures to improve outcomes. However, guidance on selecting appropriate active ingredients across different procedure types and phases remains limited. Aims: To provide international guidance on appropriate ISC actives for use with aesthetic procedures. Methods: In a simplified Delphi study, 14 experts evaluated 44 actives for use across four procedure categories (ablative energy‐based, non‐ablative energy‐based, non‐energy‐based procedures with or without skin barrier disruption) at four time points (pretreatment, peri‐treatment, aftercare, and follow‐up ≥ 1 week post‐procedure). The panelists also ranked their top five preferred actives for each procedure category and time point. Results: Ceramides, cholesterol, hyaluronic acid, niacinamide, and peptides were deemed appropriate across all procedure categories and all time points. Azelaic acid, benzoyl peroxide, cysteamine, glycolic acid, hydroquinone, lactic acid, retinoids, and salicylic acid were identified as unsuitable for use on treatment day. Ceramides and hyaluronic acid were highly ranked for pre‐treatment, peri‐treatment and aftercare, while retinoids and ferulic acid were highly ranked for pretreatment and followup. Vitamin C was ranked in the top 5 across all procedure categories and time points, except at pretreatment for non‐energy‐based without skin barrier damage. Conclusions: Safety and tolerability are primary considerations when selecting ISC actives. Ingredients with higher irritation potential, such as retinoids and acids, should be avoided during the healing phase (on treatment day and during short‐term aftercare) due to risk of irritation, as well as post‐inflammatory hyperpigmentation in skin of color.

9 February 2024 in Photochemical & Photobiological Sciences
Verified
Journal Article
Open access
PDF file
CPCelina Pihl
Celina Pihl
PBPeter Bjerring
Peter Bjerring
FAFlemming Andersen
Flemming Andersen
MHMerete Hædersdal
Merete Hædersdal
CLCatharina Lerche
Catharina Lerche
Squamous cell carcinoma represents the second most common type of keratinocyte carcinoma with ultraviolet radiation (UVR) making up the primary risk factor. Oral photoprotection aims to reduce incidence rates through oral intake of photoprotective compounds. Recently, drug repurposing has gained traction as an interesting source of chemoprevention. Because of their reported photoprotective properties, we investigated the potential of bucillamine, carvedilol, metformin, and phenformin as photoprotective compounds following oral intake in UVR-exposed hairless mice. Tumour development was observed in all groups in response to UVR, with only the positive control (Nicotinamide) demonstrating a reduction in tumour incidence (23.8%). No change in tumour development was observed in the four repurposed drug groups compared to the UV control group, whereas nicotinamide significantly reduced carcinogenesis (P = 0.00012). Metformin treatment significantly reduced UVR-induced erythema (P = 0.012), bucillamine and phenformin increased dorsal pigmentation (P = 0.0013, and P = 0.0005), but no other photoprotective effect was observed across the repurposed groups. This study demonstrates that oral supplementation with bucillamine, carvedilol, metformin, or phenformin does not affect UVR-induced carcinogenesis in hairless mice. Graphical Abstract

18 June 2025 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
CPCelina Pihl
Celina Pihl
PBPeter Bjerring
Peter Bjerring
FAFlemming Andersen
Flemming Andersen
MHMerete Hædersdal
Merete Hædersdal
CLCatharina Lerche
Catharina Lerche